Screening compound: C23H31N5O3 (P221-0924)

Screening compound: C<sub>23</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub> (P221-0924)
Screening compound: C<sub>23</sub>H<sub>31</sub>N<sub>5</sub>O<sub>3</sub> (P221-0924) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C23H31N5O3 (P221-0924)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P221-0924

Molecular Formula

C23H31N5O3 (C23 H31 N5 O3)

Compound Name

ethyl 2-[1-({[2-(3-pyridyl)-7,8-dihydro-4H-pyrazolo[1,5-a][1,4]diazepin-5(6H)-yl]carbonyl}amino)cyclohexyl]acetate

IUPAC name

ethyl 2-(1-{[2-(pyridin-3-yl)-4H5H6H7H8H-pyrazolo[15-a][14]diazepine-5-carbonyl]amino}cyclohexyl)acetate

SMILES

CCOC(CC1(CCCCC1)NC(N1Cc2cc(-c3cnccc3)nn2CCC1)=O)=O

InChI

InChI=1S/C23H31N5O3/c1-2-31-21(29)15-23(9-4-3-5-10-23)25-22(30)27-12-7-13-28-19(17-27)14-20(26-28)18-8-6-11-24-16-18/h6,8,11,14,16H,2-5,7,9-10,12-13,15,17H2,1H3,(H,25,30)

InChI Key

NMDRQNPBKLIDBW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27569705

C23H31N5O3 (P221-0924) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Hsp90-Targeted Library (11355 compounds)

Integrin Receptors Targeted library (1715 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
Targets:
  • Kinases
  • GPCR
  • Others
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with C23H31N5O3 (P221-0924) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C23H31N5O3 (P221-0924)?
Check Price and Availability of C23H31N5O3 (P221-0924), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C23H31N5O3 (P221-0924) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C23H31N5O3 (P221-0924)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C23H31N5O3 (P221-0924)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C23H31N5O3 (P221-0924) available by request